compendium.ch
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients | PLOS ONE
Novel Insights for Improvement of Tacrolimus Therapy
MEDICATION ADHERENCE FOLLOWING KIDNEY TRANSPLANTATION: A GROUNDED THEORY STUDY OF TRANSPLANT RECIPIENTS' PERSPECTIVES ANNE KA
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients | PLOS ONE
Alberta Bone Marrow and Blood Cell Transplant Program: Standard Practice Manual
Novel Insights for Improvement of Tacrolimus Therapy
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients | PLOS ONE
![Advagraf Retard Kapseln 3mg 50 Stück [!] in der Adler Apotheke](https://www.adlershop.ch/pph/100015/0/1600x1600.jpg "Advagraf Retard Kapseln 3mg 50 Stück [!] in der Adler Apotheke")
Advagraf Retard Kapseln 3mg 50 Stück [!] in der Adler Apotheke
Novel Insights for Improvement of Tacrolimus Therapy
Brief Orals
PDF) Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients
Caro Rios on Behance
Eine Bewertung der Tacrolimusformulierungen Prograf und Advagraf im primären Einsatz nach Nierentransplantation
World Journal of Transplantation
Frontiers | T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer? | Oncology
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacoki
Novel Insights for Improvement of Tacrolimus Therapy
Brief Orals
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacoki
Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systema
PDF) T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
MODEL BASED DOSING OF TACROLIMUS AFTER RENAL TRANSPLANTATION
MEDICATION ADHERENCE FOLLOWING KIDNEY TRANSPLANTATION: A GROUNDED THEORY STUDY OF TRANSPLANT RECIPIENTS' PERSPECTIVES ANNE KA
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacoki
